227 related articles for article (PubMed ID: 22422317)
1. Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus.
Seki T; Yuasa S; Fukuda K
Nat Protoc; 2012 Mar; 7(4):718-28. PubMed ID: 22422317
[TBL] [Abstract][Full Text] [Related]
2. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34
Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M
Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949
[TBL] [Abstract][Full Text] [Related]
3. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells.
Seki T; Yuasa S; Oda M; Egashira T; Yae K; Kusumoto D; Nakata H; Tohyama S; Hashimoto H; Kodaira M; Okada Y; Seimiya H; Fusaki N; Hasegawa M; Fukuda K
Cell Stem Cell; 2010 Jul; 7(1):11-4. PubMed ID: 20621043
[No Abstract] [Full Text] [Related]
4. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
[TBL] [Abstract][Full Text] [Related]
5. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
Ye H; Wang Q
Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
[TBL] [Abstract][Full Text] [Related]
6. Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Mononuclear Cells Using Sendai Virus.
Soares FA; Pedersen RA; Vallier L
Methods Mol Biol; 2016; 1357():23-31. PubMed ID: 25687300
[TBL] [Abstract][Full Text] [Related]
7. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells (iPSCs) derived from frontotemporal dementia patient's peripheral blood mononuclear cells.
Lee HK; Morin P; Wells J; Hanlon EB; Xia W
Stem Cell Res; 2015 Sep; 15(2):325-7. PubMed ID: 26246272
[TBL] [Abstract][Full Text] [Related]
10. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
Febbraro F; Chen M; Denham M
Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
[TBL] [Abstract][Full Text] [Related]
11. Generation of human induced pluripotent stem cells from cord blood cells.
Nishishita N; Takenaka C; Fusaki N; Kawamata S
J Stem Cells; 2011; 6(3):101-8. PubMed ID: 23264996
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of a human iPSC line (UAMi005-A) from a patient with nonketotic hyperglycinemia due to mutations in the GLDC gene.
Arribas-Carreira L; Bravo-Alonso I; López-Márquez A; Alonso-Barroso E; Briso-Montiano Á; Arroyo I; Ugarte M; Pérez B; Pérez-Cerdá C; Rodríguez-Pombo P; Richard E
Stem Cell Res; 2019 Aug; 39():101503. PubMed ID: 31349202
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
14. Generation of transgene-free human induced pluripotent stem cells with an excisable single polycistronic vector.
Papapetrou EP; Sadelain M
Nat Protoc; 2011 Aug; 6(9):1251-73. PubMed ID: 21886095
[TBL] [Abstract][Full Text] [Related]
15. The Efficacy and Safety of Sendai Viral Reprograming of Mouse Primary Cells Using Human Vectors.
Tarnawski L; Eugster E; DeCamp L; Jovinge S
Cell Reprogram; 2019 Apr; 21(2):78-88. PubMed ID: 30969880
[TBL] [Abstract][Full Text] [Related]
16. Generation of two human iPSC lines (MDCUi001-A and MDCUi001-B) from dermal fibroblasts of a Thai patient with X-linked osteogenesis imperfecta using integration-free Sendai virus.
Tongkobpetch S; Rungsiwiwut R; Pruksananonda K; Suphapeetiporn K; Shotelersuk V
Stem Cell Res; 2019 Aug; 39():101493. PubMed ID: 31326747
[TBL] [Abstract][Full Text] [Related]
17. Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation.
Tucker BA; Anfinson KR; Mullins RF; Stone EM; Young MJ
Stem Cells Transl Med; 2013 Jan; 2(1):16-24. PubMed ID: 23283489
[TBL] [Abstract][Full Text] [Related]
18. Generation of an integration-free induced pluripotent stem cell line (CSC-43) from a patient with sporadic Parkinson's disease.
Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
Stem Cell Res; 2018 Mar; 27():82-85. PubMed ID: 29334630
[TBL] [Abstract][Full Text] [Related]
19. Human transgene-free amniotic-fluid-derived induced pluripotent stem cells for autologous cell therapy.
Jiang G; Di Bernardo J; Maiden MM; Villa-Diaz LG; Mabrouk OS; Krebsbach PH; O'Shea KS; Kunisaki SM
Stem Cells Dev; 2014 Nov; 23(21):2613-25. PubMed ID: 25014361
[TBL] [Abstract][Full Text] [Related]
20. Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling.
Jin ZB; Okamoto S; Xiang P; Takahashi M
Stem Cells Transl Med; 2012 Jun; 1(6):503-9. PubMed ID: 23197854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
